Patents by Inventor Stephen Eliot Zweig

Stephen Eliot Zweig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160325112
    Abstract: An active material, suitable for implantable medical devices. The active material is a mixture, composite, or aggregate of upconverting particles and photocatalytic particles embedded in an at least infrared light conducting and gas permeable support material. The upconverting particles convert longer wavelength light into shorter wavelength light, which in turn powers the photocatalytic materials to produce cytotoxic chemicals. When embedded into an implantable medical device in a desired body location, and exposed to red or infrared light, this active material can produce cytotoxic chemicals that in turn exert a cytotoxic effect on unwanted cells, such as cancer or microbial cells, as well as perform other functions.
    Type: Application
    Filed: May 13, 2016
    Publication date: November 10, 2016
    Inventor: Stephen Eliot Zweig
  • Patent number: 8190374
    Abstract: The present invention consists of a time-temperature indicator device that has at least one parameter set to warn when a therapeutic protein drug has had a thermal history associated with increased risk of unwanted immunological activity. The indicator device is designed to remain with the drug as the drug travels throughout different links of the cold chain. In a preferred embodiment, the indicator device remains associated with the therapeutic protein from the time of manufacture up until the final few minutes before the drug is used. In alternate forms of the invention, additional parameters, including motion, light, color and turbidity may also be monitored. Novel methods for determining therapeutic protein time-temperature immunological risk parameters, and programming or adjusting the indicator device, are also disclosed.
    Type: Grant
    Filed: May 28, 2007
    Date of Patent: May 29, 2012
    Inventor: Stephen Eliot Zweig
  • Patent number: 8118991
    Abstract: The invention discloses a device and method by which dry reagent enzyme based electrochemical biosensors, which are in a relatively mature form due to the extensive amount of development pioneered by the blood glucose monitoring industry, may be simply adapted to perform tests for blood coagulation, enzymatic activity, or immunochemical assays for antigens present in a fluid sample. In particular, the utility of combining apoenzyme based dry reagent electrochemical biosensors with apoenzyme reactivation technology is taught. This combination creates a novel combination test technology capable of detecting a wide range of different analytes, and operating in a wide variety of wet or dry, in vivo or in vitro environments.
    Type: Grant
    Filed: January 22, 2007
    Date of Patent: February 21, 2012
    Inventor: Stephen Eliot Zweig
  • Publication number: 20110054305
    Abstract: Implantable medical devices, such as catheters and stents, which contain light upconverting materials as part of their construction, are disclosed. Such upconverting materials, often rare earth compounds, can convert longer wavelength light, such as light from the 600-800 nm region, which penetrates the body tissue easily, but which is too low energy to induce many chemical reactions, into shorter wavelength light, such as light above 500 nm, which penetrates only a small distance through the body tissues, but which contains enough energy to induce a greater variety of chemical reactions, including conversion of drugs such as psorlens from an inactive to an active form, activation of cytotoxic or antimicrobial photocatalysts such as TiO2, and conversion of non-target molecules to target molecules for other drug and biotherapeutic systems. Such implantable devices can potentially exert their therapeutic effects for years after administration.
    Type: Application
    Filed: August 30, 2010
    Publication date: March 3, 2011
    Inventor: Stephen Eliot Zweig
  • Patent number: 7758744
    Abstract: Diagnostic dry reagent tests capable of reacting with a single drop of whole blood and reporting both glucose and light-scattering analytes, such as chylomicrons, are taught. Such dry reagent tests may employ electrochemical detection methodologies, optical detection methodologies, or both methodologies. These tests alert diabetics to excessive levels of postprandial lipemia caused by meals with excessive amounts of fat, and thus can help reduce the risk of cardiovascular complications in diabetic patients.
    Type: Grant
    Filed: October 31, 2005
    Date of Patent: July 20, 2010
    Inventor: Stephen Eliot Zweig
  • Patent number: 7564364
    Abstract: This invention covers improved electronic time-temperature indicators with an RFID output, and other devices and methods by which the thermal history of a complex material, which may not obey a simple exponential Arrhenius law degradation equation, may be monitored, and the subsequent fitness for use of the tracked material may be quickly ascertained. In particular, the invention discloses a rapidly reprogrammable electronic time-temperature RFID tag that may be easily customized with the thermal time-temperature stability profile of an arbitrary material, using electronic data transfer methods. Using this device, a single, low-cost, generic time-temperature tag may be mass-produced, and then subsequently programmed to mimic the stability characteristics of nearly any material of interest.
    Type: Grant
    Filed: September 1, 2006
    Date of Patent: July 21, 2009
    Inventor: Stephen Eliot Zweig
  • Patent number: 7291698
    Abstract: Novel synthetic enzyme substrates, enhanced to have improved enzymatic specificity, are disclosed. These synthetic enzyme substrates consist of a substrate peptide that has had its specificity further improved by additional synthetic moieties, selected by combinatorial chemistry techniques, that act to sterically block non-target enzymes. These “steric restrictor” moieties may be labeled to produce a detectable signal upon enzymatic reaction. These novel substrates are particularly useful for improved enzyme substrate microarrays. Specific applications for improved protease substrate microarrays are discussed.
    Type: Grant
    Filed: September 3, 2002
    Date of Patent: November 6, 2007
    Inventor: Stephen Eliot Zweig
  • Patent number: 7288368
    Abstract: A membrane receptor reagent and assay is disclosed in which liposomes are bound to an evanescent wave emitting surface. Membrane receptors on the liposome's fluid lipid bilayer membrane are labeled with a fluorescent or luminescent moiety. These membrane receptors are free to diffuse randomly throughout the liposome surface, and thus tend to redistribute according to externally applied forces. The evanescent wave-emitting surface additionally contains reagents that reversibly bind to the membrane receptors, tending to bring them closer to region of high evanescent wave intensity. Test analytes that disrupt or promote the association between the membrane receptors and the surface reagents act to change the average distance between the membrane receptors and the evanescent wave emitting surface, resulting in a change in the fluorescent or luminescent signal.
    Type: Grant
    Filed: July 6, 2004
    Date of Patent: October 30, 2007
    Inventor: Stephen Eliot Zweig
  • Patent number: 7174238
    Abstract: The invention is a computerized mobile robot with an onboard internet web server, and a capability of establishing a first connection to a remote web browser on the internet for robotic control purposes, and a capability of establishing a second short range bi-directional digital radio connection to one or more nearby computerized digital radio equipped devices external to the robot. The short-range bi-directional digital radio connection will typically have a maximum range of about 300 feet. In a preferred embodiment, this short-range wireless digital connection will use the 2.4 gHz band and digital protocols following the IEEE 802.11, 802.15, or other digital communications protocol.
    Type: Grant
    Filed: September 2, 2003
    Date of Patent: February 6, 2007
    Inventor: Stephen Eliot Zweig
  • Patent number: 7166208
    Abstract: The invention discloses a methods in which dry reagent enzyme based electrochemical biosensors, which are in a relatively mature form due to the extensive amount of development pioneered by the blood glucose monitoring industry, may be simply adapted to perform tests for blood coagulation, enzymatic activity, or immunochemical assays for antigens present in a fluid sample. In particular, the utility of combining apoenzyme based dry reagent electrochemical biosensors with apoenzyme reactivation technology is taught. This combination creates a novel combination dry reagent test technology capable of detecting a wide range of different analytes.
    Type: Grant
    Filed: February 17, 2005
    Date of Patent: January 23, 2007
    Inventor: Stephen Eliot Zweig
  • Patent number: 7102526
    Abstract: This invention covers improved electronic time-temperature indicators with a visual output, and other devices and methods by which the thermal history of a complex material, which may not obey a simple exponential Arrhenius law degradation equation, may be monitored, and the subsequent fitness for use of the tracked material may be quickly ascertained. In particular, the invention discloses a rapidly reprogrammable electronic time-temperature tag that may be easily customized with the thermal time-temperature stability profile of an arbitrary material, using electronic data transfer methods. Using this device, a single, low-cost, generic time-temperature tag may be mass-produced, and then subsequently programmed to mimic the stability characteristics of nearly any material of interest.
    Type: Grant
    Filed: April 14, 2004
    Date of Patent: September 5, 2006
    Inventor: Stephen Eliot Zweig
  • Patent number: 7096090
    Abstract: The invention is a computerized mobile robotic router with an onboard internet web server, and a capability of establishing a first connection to a remote web browser on the internet for robotic control purposes, and a capability of establishing a second short range bi-directional digital radio connection to one or more nearby computerized digital radio equipped computers or devices external to the robot. The short-range bi-directional digital radio connection will typically have a maximum range of about 300 feet. In a preferred embodiment, this short-range wireless digital connection will use the 2.4 gHz band and digital protocols following the IEEE 802.11, 802.15, or other digital communications protocol.
    Type: Grant
    Filed: November 3, 2003
    Date of Patent: August 22, 2006
    Inventor: Stephen Eliot Zweig
  • Patent number: 6984307
    Abstract: Diagnostic dry reagent tests capable of reacting with a single drop of whole blood and reporting both glucose and beta-hydroxybutyrate levels are taught. Such dry reagent tests may employ electrochemical detection methodologies, optical detection methodologies, or both methodologies. These tests help facilitate the early detection of the onset of ketoacidosis in diabetes.
    Type: Grant
    Filed: October 3, 2002
    Date of Patent: January 10, 2006
    Inventor: Stephen Eliot Zweig
  • Patent number: 6950028
    Abstract: This invention covers electronic time-temperature indicators with a visual output, and other devices and methods by which the thermal history of a material may be monitored, and the subsequent fitness for use of the tracked material may be quickly ascertained. In particular, the invention discloses a rapidly reprogrammable electronic time-temperature tag that may be easily customized with the thermal time-temperature stability profile of an arbitrary material, using electronic data transfer methods. Using this device, a single, low-cost, generic time-temperature tag may be mass-produced, and then subsequently programmed to mimic the stability characteristics of nearly any material of interest.
    Type: Grant
    Filed: August 5, 2003
    Date of Patent: September 27, 2005
    Inventor: Stephen Eliot Zweig
  • Publication number: 20040241765
    Abstract: A membrane receptor reagent and assay is disclosed in which liposomes are bound to an evanescent wave emitting surface. Membrane receptors on the liposome's fluid lipid bilayer membrane are labeled with a fluorescent or luminescent moiety. These membrane receptors are free to diffuse randomly throughout the liposome surface, and thus tend to redistribute according to externally applied forces. The evanescent wave-emitting surface additionally contains reagents that reversibly bind to the membrane receptors, tending to bring them closer to region of high evanescent wave intensity. Test analytes that disrupt or promote the association between the membrane receptors and the surface reagents act to change the average distance between the membrane receptors and the evanescent wave emitting surface, resulting in a change in the fluorescent or luminescent signal.
    Type: Application
    Filed: July 6, 2004
    Publication date: December 2, 2004
    Inventor: Stephen Eliot Zweig
  • Publication number: 20040212508
    Abstract: The present invention consists of a time-temperature indicator device that has at least one parameter set to warn when a therapeutic protein drug has had a thermal history associated with increased risk of unwanted immunological activity. The indicator device is designed to remain with the drug as the drug travels throughout different links of the cold chain. In a preferred embodiment, the indicator device remains associated with the therapeutic protein from the time of manufacture up until the final few minutes before the drug is used. In alternate forms of the invention, additional parameters, including motion, light, and turbidity may also be monitored. Novel methods for determining therapeutic protein time-temperature immunological risk parameters, and programming or adjusting the indicator device, are also disclosed.
    Type: Application
    Filed: December 29, 2003
    Publication date: October 28, 2004
    Inventor: Stephen Eliot Zweig
  • Publication number: 20040212509
    Abstract: This invention covers improved electronic time-temperature indicators with a visual output, and other devices. and methods by which the thermal history of a complex material, which may not obey a simple exponential Arrhenius law degradation equation, may be monitored, and the subsequent fitness for use of the tracked material may be quickly ascertained. In particular, the invention discloses a rapidly reprogrammable electronic time-temperature tag that may be easily customized with the thermal time-temperature stability profile of an arbitrary material, using electronic data transfer methods. Using this device, a single, low-cost, generic time-temperature tag may be mass-produced, and then subsequently programmed to mimic the stability characteristics of nearly any material of interest.
    Type: Application
    Filed: April 14, 2004
    Publication date: October 28, 2004
    Inventor: Stephen Eliot Zweig
  • Publication number: 20040212507
    Abstract: This invention covers electronic time-temperature indicators with a visual output, and other devices and methods by which the thermal history of a material may be monitored, and the subsequent fitness for use of the tracked material may be quickly ascertained. In particular, the invention discloses a rapidly reprogrammable electronic time-temperature tag that may be easily customized with the thermal time-temperature stability profile of an arbitrary material, using electronic data transfer methods. Using this device, a single, low-cost, generic time-temperature tag may be mass-produced, and then subsequently programmed to mimic the stability characteristics of nearly any material of interest.
    Type: Application
    Filed: August 5, 2003
    Publication date: October 28, 2004
    Inventor: Stephen Eliot Zweig
  • Patent number: 6790632
    Abstract: A membrane receptor reagent and assay is disclosed in which liposomes are bound to an evanescent wave emitting surface. Membrane receptors on the liposome's fluid lipid bilayer membrane are labeled with a fluorescent or luminescent moiety. These membrane receptors are free to diffuse randomly throughout the liposome surface, and thus tend to redistribute according to externally applied forces. The evanescent wave-emitting surface additionally contains reagents that reversibly bind to the membrane receptors, tending to bring them closer to region of high evanescent wave intensity. Test analytes that disrupt or promote the association between the membrane receptors and the surface reagents act to change the average distance between the membrane receptors and the evanescent wave emitting surface, resulting in a change in the fluorescent or luminescent signal.
    Type: Grant
    Filed: May 23, 2003
    Date of Patent: September 14, 2004
    Inventor: Stephen Eliot Zweig
  • Publication number: 20040033624
    Abstract: A membrane receptor reagent and assay is disclosed in which liposomes are bound to an evanescent wave emitting surface. Membrane receptors on the liposome's fluid lipid bilayer membrane are labeled with a fluorescent or luminescent moiety. These membrane receptors are free to diffuse randomly throughout the liposome surface, and thus tend to redistribute according to externally applied forces. The evanescent wave-emitting surface additionally contains reagents that reversibly bind to the membrane receptors, tending to bring them closer to region of high evanescent wave intensity. Test analytes that disrupt or promote the association between the membrane receptors and the surface reagents act to change the average distance between the membrane receptors and the evanescent wave emitting surface, resulting in a change in the fluorescent or luminescent signal.
    Type: Application
    Filed: May 23, 2003
    Publication date: February 19, 2004
    Inventor: Stephen Eliot Zweig